
European Journal of Medicinal Chemistry p. 122 - 131 (2013)
Update date:2022-08-05
Topics:
Elsayed, Mohamed S.A.
El-Araby, Moustafa E.
Serya, Rabah A.T.
El-Khatib, Ahmed H.
Linscheid, Michael W.
Abouzid, Khaled A.M.
This study is concerned with the implementation of structure-based techniques for the design of new heterocyclic compounds based on pseudosaccharine scaffold with protein kinase inhibition activity. This nucleus was exploited based on the well-known quinazoline core and its interactions with several protein kinases. Two series of compounds employing this new scaffold were synthesized and evaluated at enzymatic and cellular levels. Compound 9b displayed broad spectrum antiproliferative activity on NCI 60-cell lines panel with mean GI50 of 5.4 μM. Investigation of the molecular mechanism showed probable inhibitory activity against Src kinase.
View MoreBeijing Harmony Chemical Co., Ltd.
Contact:86-010-84956928
Address:Room 207, Jin feng he B building, No 8 Xin Jie Kou Wai Street, Xi Cheng District, Beijing,PRC. 10008
MedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
ZHANGJIAGANG FREE TRADE ZONE YONG HAN INTERNATIONAL TRADING CO., LTD(expird)
Contact:86 512 57910558
Address:qianjin M road
Shanghai Longjin Metallic Material Co., Ltd.
website:http://www.shlongjin.cn/
Contact:021-56517503,56502257
Address:No.16, Lane 555, Chengyin Road, Shanghai
JIANGXI ZHANGFENG CHEMICAL CO., LTD.
Contact:+86-0799-3413066
Address:Xiyuan village, Xiabu Town, Xiangdong District
Doi:10.1021/bi400211q
(2013)Doi:10.1021/jo302800t
(2013)Doi:10.1016/j.bioorg.2020.103851
(2020)Doi:10.1002/adsc.201701128
(2018)Doi:10.1039/c3ra22955f
(2013)Doi:10.1039/c3nj00127j
(2013)